Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:09:01.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record and related information. This reflects a permissions or server issue rather than an update to the study content.
    Difference
    19%
    Check dated 2026-09-20T22:22:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, replacing the previous version string. This indicates a small update to the site version.
    Difference
    0.1%
    Check dated 2026-08-30T16:42:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5. This indicates a backend/template update rather than any modification to study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-09T11:00:05.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor backend/software update to the page. No study content or patient-facing information is altered by this change.
    Difference
    0.1%
    Check dated 2026-07-25T17:45:00.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates the page has been updated to a newer version without altering study details or functionality.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:18.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.